Iridian Asset Management LLC CT decreased its holdings in shares of Albemarle Co. (NYSE:ALB) by 2.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,383,042 shares of the specialty chemicals company’s stock after selling 39,233 shares during the period. Iridian Asset Management LLC CT’s holdings in Albemarle were worth $176,877,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also made changes to their positions in the company. Kornitzer Capital Management Inc. KS purchased a new position in shares of Albemarle during the 4th quarter valued at approximately $1,357,000. Dividend Assets Capital LLC lifted its position in shares of Albemarle by 1.3% during the 4th quarter. Dividend Assets Capital LLC now owns 187,750 shares of the specialty chemicals company’s stock valued at $24,011,000 after buying an additional 2,355 shares in the last quarter. Wedge Capital Management L L P NC lifted its position in shares of Albemarle by 8.0% during the 4th quarter. Wedge Capital Management L L P NC now owns 63,747 shares of the specialty chemicals company’s stock valued at $8,153,000 after buying an additional 4,740 shares in the last quarter. Westbourne Investment Advisors Inc. lifted its position in shares of Albemarle by 90.6% during the 4th quarter. Westbourne Investment Advisors Inc. now owns 7,025 shares of the specialty chemicals company’s stock valued at $898,000 after buying an additional 3,340 shares in the last quarter. Finally, LMR Partners LLP lifted its position in shares of Albemarle by 133.1% during the 4th quarter. LMR Partners LLP now owns 21,170 shares of the specialty chemicals company’s stock valued at $2,707,000 after buying an additional 12,087 shares in the last quarter. Hedge funds and other institutional investors own 88.03% of the company’s stock.

A number of brokerages have recently issued reports on ALB. Jefferies Group reiterated a “buy” rating on shares of Albemarle in a research report on Tuesday, October 24th. Royal Bank of Canada raised their price objective on Albemarle from $149.00 to $155.00 and gave the company an “outperform” rating in a report on Friday, November 10th. Goldman Sachs Group lowered Albemarle from a “buy” rating to a “neutral” rating and raised their price objective for the company from $139.66 to $142.00 in a report on Friday, October 6th. Zacks Investment Research lowered Albemarle from a “buy” rating to a “hold” rating in a report on Tuesday, December 19th. Finally, Oppenheimer raised their price objective on Albemarle from $133.00 to $157.00 and gave the company an “outperform” rating in a report on Monday, October 16th. Nine equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $127.78.

Shares of Albemarle Co. (NYSE:ALB) traded down $2.39 on Thursday, hitting $109.20. The company’s stock had a trading volume of 1,961,798 shares, compared to its average volume of 2,275,397. Albemarle Co. has a twelve month low of $90.35 and a twelve month high of $144.99. The firm has a market cap of $12,100.00, a P/E ratio of 38.99, a PEG ratio of 1.46 and a beta of 1.69. The company has a quick ratio of 1.56, a current ratio of 2.11 and a debt-to-equity ratio of 0.35.

Albemarle (NYSE:ALB) last issued its earnings results on Wednesday, November 8th. The specialty chemicals company reported $1.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.07 by $0.01. Albemarle had a return on equity of 11.61% and a net margin of 30.07%. The business had revenue of $755.00 million during the quarter, compared to the consensus estimate of $732.19 million. During the same period last year, the company earned $0.91 EPS. The company’s revenue for the quarter was up 15.4% on a year-over-year basis. equities analysts expect that Albemarle Co. will post 4.46 EPS for the current year.

The business also recently announced a quarterly dividend, which was paid on Tuesday, January 2nd. Shareholders of record on Friday, December 15th were paid a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 1.17%. The ex-dividend date was Thursday, December 14th. Albemarle’s dividend payout ratio (DPR) is presently 45.71%.

TRADEMARK VIOLATION WARNING: “Albemarle Co. (ALB) Stake Lessened by Iridian Asset Management LLC CT” was published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this piece on another site, it was illegally copied and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this piece can be read at https://theolympiareport.com/2018/02/01/albemarle-co-alb-stake-lessened-by-iridian-asset-management-llc-ct.html.

About Albemarle

Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.

Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Co. (NYSE:ALB).

Institutional Ownership by Quarter for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.